nanotech investing Nuvation Bio to Present Pivotal IBTROZI® Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 17 March
nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update 02 March
nanotech investing Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 17 February
